161 related articles for article (PubMed ID: 17717230)
1. Hydroxyethyl starch: the effect of molecular weight and degree of substitution on intravascular retention in vivo.
Hitosugi T; Saito T; Suzuki S; Kubota I; Shoda E; Shimizu T; Oi Y
Anesth Analg; 2007 Sep; 105(3):724-8. PubMed ID: 17717230
[TBL] [Abstract][Full Text] [Related]
2. Impact of the C2/C6 ratio of high-molecular-weight hydroxyethyl starch on pharmacokinetics and blood coagulation in pigs.
Schramm S; Thyes C; Frascarolo P; Buclin T; Burki M; Fisch A; Burmeister MA; Asmis L; Spahn DR
Anesthesiology; 2007 Sep; 107(3):442-51. PubMed ID: 17721247
[TBL] [Abstract][Full Text] [Related]
3. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
[TBL] [Abstract][Full Text] [Related]
4. [The in vivo molecular weight and renal threshold of hydroxyethyl starch in the example of molar substituted HES70/0/5].
Förster H; Lehmann G; Asskali F
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jan; 36(1):31-7. PubMed ID: 11227306
[TBL] [Abstract][Full Text] [Related]
5. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
Kröll W; Pölz W; Colombo T; Steindorfer P
Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
[TBL] [Abstract][Full Text] [Related]
6. [The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers].
Asskali F; Förster H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Sep; 34(9):537-41. PubMed ID: 10542895
[TBL] [Abstract][Full Text] [Related]
7. Resuscitation from hemorrhagic shock with hydroxyethyl starch and coagulation changes.
Cabrales P; Tsai AG; Intaglietta M
Shock; 2007 Oct; 28(4):461-7. PubMed ID: 17558350
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of capillary leakage by hydroxyethyl starch (130/0.42) in a porcine model of septic shock.
Marx G; Pedder S; Smith L; Swaraj S; Grime S; Stockdale H; Leuwer M
Crit Care Med; 2006 Dec; 34(12):3005-10. PubMed ID: 16971858
[TBL] [Abstract][Full Text] [Related]
9. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
[TBL] [Abstract][Full Text] [Related]
10. Coagulation disorders caused by hydroxyethyl starch.
Treib J; Haass A; Pindur G
Thromb Haemost; 1997 Sep; 78(3):974-83. PubMed ID: 9308738
[TBL] [Abstract][Full Text] [Related]
11. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
Treib J; Haass A; Pindur G; Grauer MT; Jung F; Wenzel E; Schimrigk K
Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyethyl starch does not cross the blood-brain or the placental barrier but the perineurium of peripheral nerves in infused animals.
Ständer S; Bone HG; Machens HG; Aberle T; Burchard W; Prien T; Luger TA; Metze D
Cell Tissue Res; 2002 Dec; 310(3):279-87. PubMed ID: 12457226
[TBL] [Abstract][Full Text] [Related]
13. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis.
Niemi TT; Kuitunen AH
Acta Anaesthesiol Scand; 2005 Mar; 49(3):373-8. PubMed ID: 15752404
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].
Mishler JM
Infusionsther Klin Ernahr; 1980 Apr; 7(2):96-102. PubMed ID: 6159323
[TBL] [Abstract][Full Text] [Related]
15. [Blood volume replacement and hemodilution with hydroxyethyl starch].
Messmer K; Jesch F
Infusionsther Klin Ernahr; 1978 Jun; 5(3):169-77. PubMed ID: 78893
[TBL] [Abstract][Full Text] [Related]
16. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
17. [Comparative effects of low and medium molecular hydroxyethyl starch (HES) solutions on hemorrhagic shock in rats].
Yoneko M; Suzuki Y; Kojima J
Masui; 2012 Jan; 61(1):57-63. PubMed ID: 22338861
[TBL] [Abstract][Full Text] [Related]
18. [Hydroxyethyl starch--an interim report].
Weidhase R; Faude K; Weidhase R
Anaesthesiol Reanim; 1998; 23(1):4-14. PubMed ID: 9553245
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
Koscielny J; Jung F; Mrowietz C; Pindur G; Förster H; Schimetta W; Kiesewetter H; Wenzel E
Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833
[TBL] [Abstract][Full Text] [Related]
20. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
